Sanofi releases Cenovis brands

Published: 2013-06-18 06:57:00

Updated: 2013-06-18 06:57:00

Sanofi-Aventis Korea is bringing Cenovis Pro, one of the most trusted names in Australia's health care industry, to the nation’s pharmacy market, thus expanding its business horizons beyond the traditional pharmaceutical segment.

The Seoul-based company said Monday that it plans to release fi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK